Neutrophil elastase and matrix metalloproteinase 12 in cystic fibrosis lung disease

Area of Science:

• Pulmonary Medicine
• Molecular Biology
• Genetics

Background:

• Chronic lung disease is a primary cause of mortality in cystic fibrosis (CF) patients.
• Neutrophil elastase (NE), released from neutrophils, is a key risk factor for early CF lung disease progression.
• The in vivo role of NE and other proteases in CF pathogenesis requires further elucidation.

Purpose of the Study:

• To review recent findings on the role of proteases in CF lung disease pathogenesis.
• To explore the contribution of NE and other proteases using mouse models and novel FRET sensors.
• To identify potential therapeutic targets for mitigating CF lung damage.

Main Methods:

• Utilized βENaC-overexpressing (βENaC-Tg) mice that exhibit CF-like lung disease.
• Employed protease-specific Förster resonance energy transfer (FRET) sensors for in vivo protease activity analysis.
• Reviewed existing literature on protease function in CF lung disease models.

Main Results:

• Demonstrated NE's involvement in neutrophilic airway inflammation, mucus hypersecretion, and structural lung damage in CF models.
• Identified matrix metalloproteinase 12 (MMP12) as another protease contributing to early lung damage in βENaC-Tg mice.
• Confirmed the in vivo roles of NE and MMP12 in CF lung disease progression.

Conclusions:

• NE and MMP12, released from activated immune cells in mucus-obstructed airways, play significant pathogenetic roles in CF lung disease.
• Targeting NE and MMP12 presents a potential therapeutic strategy to prevent or delay irreversible structural lung damage in CF patients.
• Further research into protease inhibition could lead to novel treatments for cystic fibrosis.